See also: Immune Reconstitution Inflammatory Syndrome (IRIS)

Selected Fact Sheets and Recent Articles

• Why Inflammation Is a Hot Topic.  Basic background information about inflammation from Berkeley Wellness.  Although this article does not focus specifically on inflammation and HIV, it provides a good overview of inflammation, its functions, and the role of chronic inflammation in some diseases.
• Physical Activity by HIV Group Tied to Heart Markers and Inflammation.  (September 2016, TheBodyPro)
• CAD in men with HIV linked to inflammatory biomarkers.  (August 2016, Healio)
• Statin decreases arterial inflammation, immune activation in patients with HIV. (July 2016, Healio)
• Newly initiated ART does not reduce arterial inflammation in HIV patients.  (June 2016, Healio)
• Breaking a “Vicious Circle”: Controlling HIV Reservoirs by Targeting Inflammation.  (April 2016, amfAR)
• Hand OA [osteoarthritis] More Prevalent With HIV Infection – Metabolic syndrome further adds to hand OA risk  (April 2016, MedPage Today)
• What Is Chronic Inflammation and Why Is It Such a Big Deal for People with HIV?  (April 2016, Hepmag)
• Bodyweight influences risk for inflammation, mortality among HIV patients starting ART.  (April 2016, Healio)
• Inflammation Markers Tied to Worse Kidney Function in Men Taking Antiretroviral Therapy.  (October 2015, TheBodyPro)
• Weight Gain Exacerbates Inflammation in People Living with HIV.  (October 2015, Beta Blog)
• Fat Tissue May Be Another Part of HIV Reservoir.  (September 2015, Poz)
• The Low-Down on Inflammation from an HIV Doctor.  (August 2015, Beta Blog)
• Inflammation and gut leakage remains elevated in people with HIV despite early antiretroviral treatment.  (March 2015, AIDSmap)
• Inflammation Persists Despite Very Early HIV Treatment.  (February 2015, TheBodyPro)
• Gum Disease Can Lead Dormant HIV to Replicate.  (January 2015, Poz)
• Inflammation May Lead to Diabetes in People on HIV Meds.  (October 2014, Poz)
• Inflammatory markers associated with development of diabetes in people taking HIV therapy.  (October 2014, AIDSmap)
• Rosuvastatin may be partially effective in moderating residual immune activation on ART.  (September/October 2014, HIV Treatment Bulletin)
• Inflammation/Activation Markers Drop With ATV, DRV, RAL, But Not Completely – ACTG Study.  (July 2014, NATAP)
• Treating HIV Very Early May Limit Inflammation, Gut Damage.  (April 2014, Poz)
• Arterial Inflammation Tied to High-Risk Coronary Plaques in HIV Group. (March 2014, NATAP)
• Brain Markers of Inflammation Drop to Normal With Early ART. (March 2014, NATAP)
• Fighting the fire [inflammation].  (Winter 2014, Positively Aware)
• New Piece of the Inflammation Puzzle Uncovered; CD4 Pyroptosis Mechanism Described.  (December 2013, Project Inform)
• HIV-positive people not on antiretrovirals are prone to inflammation-related bone loss.  (October 2013, AIDSmap)
• Liver fibrosis linked to immune activation in HIV/HCV co-infected women.  (October 2013, AIDSmap)
• Gut Bacteria May Cause Inflammation, Aggravate HIV Disease.  (July 2013, Poz)
• Statins Take Bite Out of Cancer Risk in People With HIV.  (July 2013, Poz)
• Complications of HIV and its treatment, Impressions from the 20th CROI.  (March 2013, NATAP)
• Inflammation and HIV at CROI 2013.  (March 2013, NATAP)
• Cardiovascular Disease and Co-morbidities in HIV.  (March 2013, NATAP)
• Antiretrovials Reduce Cellular Inflammation Among Elite Controllers of HIV.  (March 2013, Poz)
• Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study.  (March 2013, NATAP)
• Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect.  (March 2013, AIDSmap)
• Cardiovascular Disease Risk Remains High in HIV Elite Controllers. (October 2012, Poz)
• Thalidomide for HIV-Related IRIS Shows Promise. (September 2012, Poz)
• Low levels of innate immune activation and high levels of gut antibodies may protect people from HIV.  (August 2012, AIDSmap)
• Might Aspirin Reduce Cardiovascular Risk in People With HIV?  (August 2012, Poz)
• Untreated HIV infection is associated with higher blood alcohol levels. (April 2012, AIDSmap)
• Low HIV viral load doesn’t cause inflammation or increase the risk of death. (November 2011, AIDSmap)
• Long-Term Tenofovir for Chronic Hepatitis B Reduces Liver Inflammation and Cirrhosis. (November 2011, HIVandhepatitis)
• Low Levels of HIV in the Blood Aren’t Connected to Inflammation or Death. (November 2011, Poz)
• Treatment with statins reduces mortality risk for patients taking effective HIV therapy. (August 2011, AIDSmap)